DNA Methylation and Gene Expression in Osteosarcoma
Author Information
Author(s): Sadikovic Bekim, Yoshimoto Maisa, Al-Romaih Khaldoun, Maire Georges, Zielenska Maria, Squire Jeremy A.
Primary Institution: The Hospital for Sick Children, Toronto, Ontario, Canada
Hypothesis
The study aims to develop an integrative approach for analyzing high-resolution epigenomic, genomic, and gene expression profiles in osteosarcoma cell lines compared to normal human osteoblasts.
Conclusion
The study provides comprehensive evidence of the cumulative roles of epigenetic and genetic mechanisms in the deregulation of gene expression networks in osteosarcoma.
Supporting Evidence
- An integrative high-resolution approach for interrogation of genome-wide tumour-specific changes in DNA methylation was developed.
- This study provided the first genomic DNA methylation maps for osteosarcoma cell lines.
- Significant changes in gene expression were observed in U2OS and MG63 cells relative to normal osteoblast levels.
- Integration of epigenomic, genomic imbalance, and gene expression profiles revealed common patterns in both cell lines.
Takeaway
Researchers looked at how changes in DNA and gene activity are linked in a type of bone cancer called osteosarcoma, finding important patterns that could help understand the disease better.
Methodology
The study used a combination of Affymetrix Promoter Tilling Arrays for DNA methylation, Agilent array-CGH for genomic imbalance, and Affymetrix Gene 1.0 platform for gene expression analysis.
Limitations
The study's approach may be limited by the resolution of the arrays used and the indirect nature of detecting differentially methylated genes.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website